Point72 Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-3
| Closed | -$195 | – | 2211 |
|
2023
Q3 | $195 | Sell |
3
-197
| -99% | -$12.8K | ﹤0.01% | 1696 |
|
2023
Q2 | $20.4K | Sell |
200
-205
| -51% | -$20.9K | ﹤0.01% | 1251 |
|
2023
Q1 | $71.7K | Buy |
+405
| New | +$71.7K | ﹤0.01% | 1200 |
|
2022
Q2 | – | Sell |
-12,753
| Closed | -$5.58M | – | 1395 |
|
2022
Q1 | $5.58M | Buy |
12,753
+2,800
| +28% | +$1.22M | 0.02% | 613 |
|
2021
Q4 | $4.36M | Buy |
+9,953
| New | +$4.36M | 0.02% | 659 |
|
2020
Q1 | – | Sell |
-2,311
| Closed | -$1.34M | – | 1088 |
|
2019
Q4 | $1.34M | Sell |
2,311
-1,914
| -45% | -$1.11M | 0.01% | 636 |
|
2019
Q3 | $2.78M | Buy |
+4,225
| New | +$2.78M | 0.02% | 505 |
|
2019
Q2 | – | Sell |
-2,537
| Closed | -$1.79M | – | 1450 |
|
2019
Q1 | $1.79M | Buy |
+2,537
| New | +$1.79M | 0.01% | 618 |
|
2017
Q3 | – | Sell |
-694
| Closed | -$385K | – | 936 |
|
2017
Q2 | $385K | Buy |
+694
| New | +$385K | ﹤0.01% | 669 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 892 |
|
2016
Q1 | – | Sell |
-14,728
| Closed | -$8.94M | – | 801 |
|
2015
Q4 | $8.94M | Buy |
14,728
+14,039
| +2,038% | +$8.52M | 0.07% | 294 |
|
2015
Q3 | $354K | Sell |
689
-697
| -50% | -$358K | ﹤0.01% | 611 |
|
2015
Q2 | $606K | Buy |
+1,386
| New | +$606K | ﹤0.01% | 587 |
|